User:OniriQ/sandbox

Nicolas Rognin
Nicolas Rognin
	Dr. Rognin in 2010
Born	1974; Voiron, France, European Union
Citizenship	France;
Spouse	Not disclosed (2003–present)
	Scientific career
Fields	Science; Physics; Computer science; Electrical engineering;
Institutions	University of Lyon (1996–2003); Bracco Group (2003–2010); Toshiba (2003-present);

This is the user sandbox of OniriQ. A user sandbox is a subpage of the user's user page. It serves as a testing spot and page development space for the user and is not an encyclopedia article. Create or edit your own sandbox here.

Other sandboxes: Main sandbox | Template sandbox

Finished writing a draft article? Are you ready to request review of it by an experienced editor for possible inclusion in Wikipedia? Submit your draft for review!

This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft.

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Easy tools: Citation bot (help) | Advanced: Fix bare URLs
This page was last edited by Cydebot (talk | contribs) 5 years ago. (Update timer)

Finished writing a draft article? Are you ready to request an experienced editor review it for possible inclusion in Wikipedia? Submit your draft for review!

Nicolas Georges Rognin is a French scientist who conceptualizes and develops solutions for tissue (biology) characterization in cancer diagnosis^[1]^[2]^[3]^[4] by medical imaging and ultrasound molecular imaging^[5]^[6]^[7]^[8]^[9].

References[edit]

^ Rognin NG. Outils de simulation et de quantification en imagerie de contraste échographique [Thèse de Doctorat (PhD)]. Université Claude Bernard (Lyon, France); 2002; 217 p. [1]
^ Wiart M, Rognin NG, Berthezene Y, Nighoghossian N, Froment JC, Baskurt A. Perfusion-based segmentation of the human brain using similarity mapping. Magn Reson Med. 2001 Feb;45(2):261-8. [2]
^ Rognin NG, Frinking P, Costa M, Arditi M. In-vivo perfusion quantification by contrast ultrasound: Validation of the use of linearized video data vs. raw RF data. in Proc. IEEE Ultrasonics Symp. (China, Beijing), 2008 Nov;1690–1693. [3]
^ Rognin NG, Arditi M, Mercier L, Frinking PJ, Schneider M, Perrenoud G, Anaye A, Meuwly JY, Tranquart F. Parametric imaging for characterizing focal liver lesions in contrast-enhanced ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control. 2010 Nov;57(11):2503-11. [4]
^ Klibanov AL, Hughes MS, Marsh JN, Hall CS, Miller JG, Wible JH, Brandenburger GH. Targeting of ultrasound contrast material. An in vitro feasibility study. Acta Radiol Suppl. 1997;412:113-20. [5]
^ Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001 Oct 23;104(17):2107-12. [6]
^ Willmann JK, Lutz AM, Paulmurugan R, Patel MR, Chu P, Rosenberg J, Gambhir SS. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology. 2008 Sep;248(3):936-44. [7]
^ Rognin NG, Unnikrishnan S, Guenette G, Kanayama Y, Woods R, Sanders C, Kamiyama N, Klibanov AL. Molecular Ultrasound Imaging Enhancement by Volumic Acoustic Radiation Force (VARF). World Molecular Imaging Congress (Dublin, Ireland). 2012 Sept. [8]
^ Sugimoto K, Moriyasu F, Negishi Y, Hamano N, Oshiro H, Rognin NG, Yoshida T, Kamiyama N, Aramaki Y, Imai Y. Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft. J Ultrasound Med. 2012 Dec;31(12):1909-16. [9]

[1] Rognin NG. Outils de simulation et de quantification en imagerie de contraste échographique [Thèse de Doctorat (PhD)]. Université Claude Bernard (Lyon, France); 2002; 217 p. [1]

[2] Wiart M, Rognin NG, Berthezene Y, Nighoghossian N, Froment JC, Baskurt A. Perfusion-based segmentation of the human brain using similarity mapping. Magn Reson Med. 2001 Feb;45(2):261-8. [2]

[3] Rognin NG, Frinking P, Costa M, Arditi M. In-vivo perfusion quantification by contrast ultrasound: Validation of the use of linearized video data vs. raw RF data. in Proc. IEEE Ultrasonics Symp. (China, Beijing), 2008 Nov;1690–1693. [3]

[4] Rognin NG, Arditi M, Mercier L, Frinking PJ, Schneider M, Perrenoud G, Anaye A, Meuwly JY, Tranquart F. Parametric imaging for characterizing focal liver lesions in contrast-enhanced ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control. 2010 Nov;57(11):2503-11. [4]

[5] Klibanov AL, Hughes MS, Marsh JN, Hall CS, Miller JG, Wible JH, Brandenburger GH. Targeting of ultrasound contrast material. An in vitro feasibility study. Acta Radiol Suppl. 1997;412:113-20. [5]

[6] Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001 Oct 23;104(17):2107-12. [6]

[7] Willmann JK, Lutz AM, Paulmurugan R, Patel MR, Chu P, Rosenberg J, Gambhir SS. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology. 2008 Sep;248(3):936-44. [7]

[8] Rognin NG, Unnikrishnan S, Guenette G, Kanayama Y, Woods R, Sanders C, Kamiyama N, Klibanov AL. Molecular Ultrasound Imaging Enhancement by Volumic Acoustic Radiation Force (VARF). World Molecular Imaging Congress (Dublin, Ireland). 2012 Sept. [8]

[9] Sugimoto K, Moriyasu F, Negishi Y, Hamano N, Oshiro H, Rognin NG, Yoshida T, Kamiyama N, Aramaki Y, Imai Y. Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft. J Ultrasound Med. 2012 Dec;31(12):1909-16. [9]

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]